Does REGORAFENIB Cause Myocardial infarction? 49 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Myocardial infarction have been filed in association with REGORAFENIB (Stivarga). This represents 0.5% of all adverse event reports for REGORAFENIB.
49
Reports of Myocardial infarction with REGORAFENIB
0.5%
of all REGORAFENIB reports
27
Deaths
25
Hospitalizations
How Dangerous Is Myocardial infarction From REGORAFENIB?
Of the 49 reports, 27 (55.1%) resulted in death, 25 (51.0%) required hospitalization, and 6 (12.2%) were considered life-threatening.
Is Myocardial infarction Listed in the Official Label?
Yes, Myocardial infarction is listed as a known adverse reaction in the official FDA drug label for REGORAFENIB.
What Other Side Effects Does REGORAFENIB Cause?
Off label use (1,906)
Fatigue (1,530)
Palmar-plantar erythrodysaesthesia syndrome (1,230)
Diarrhoea (1,221)
Decreased appetite (941)
Asthenia (825)
Death (813)
Dysphonia (702)
Nausea (688)
Pain in extremity (686)
What Other Drugs Cause Myocardial infarction?
ROSIGLITAZONE (17,018)
TESTOSTERONE (3,396)
ADALIMUMAB (3,214)
SACUBITRIL\VALSARTAN (3,120)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (2,391)
APIXABAN (2,010)
TICAGRELOR (1,749)
LENALIDOMIDE (1,712)
ETANERCEPT (1,693)
METFORMIN\ROSIGLITAZONE (1,640)
Which REGORAFENIB Alternatives Have Lower Myocardial infarction Risk?
REGORAFENIB vs REGORAFENIB\REGORAFENIB
REGORAFENIB vs RELATLIMAB
REGORAFENIB vs RELPAX
REGORAFENIB vs RELUGOLIX
REGORAFENIB vs REMDESIVIR